NUVISAN has access to non-public data related to 3 million different structures comprising about 3 billion bioactivity and other compound measurements, contained in the Life Science Database. With this wealth of data, NUVISAN is in the position to generate proprietary machine learning and Artificial Intelligence (AI) models to support compound selection and optimization across a wide variety of endpoints. In addition, NUVISAN with decision-relevant information not available with compounds selected from other sources. Hence, the Life Science Database will make sure to use all available information to arrive at suitable bioactive chemical matter faster, and with less experimental cost.